Related references
Note: Only part of the references are listed.Benefits From Antidepressants Synthesis of 6-Week Patient-Level Outcomes From Double-blind Placebo-Controlled Randomized Trials of Fluoxetine and Venlafaxine
Robert D. Gibbons et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Effects of interferon-alpha on rhesus monkeys: A nonhuman primate model of cytokine-induced depression
Jennifer C. Felger et al.
BIOLOGICAL PSYCHIATRY (2007)
When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders
CL Raison et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Last observation carry-forward and last observation analysis
J Shao et al.
STATISTICS IN MEDICINE (2003)
Depression in cancer: New developments regarding diagnosis and treatment
CL Raison et al.
BIOLOGICAL PSYCHIATRY (2003)
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy
L Capuron et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH
O Witzke et al.
CLINICAL ENDOCRINOLOGY (2003)
Interleukin-2 regulates membrane potentials and calcium channels via μ opioid receptors in rat dorsal root ganglion neurons
P Song et al.
NEUROPHARMACOLOGY (2002)
A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance
E Goleva et al.
JOURNAL OF IMMUNOLOGY (2002)
p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma
E Irusen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2002)
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-α treatments in cancer patients
L Capuron et al.
PSYCHOSOMATIC MEDICINE (2001)
Paroxetine for the prevention of depression induced by high-dose interferon alfa
DL Musselman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment
CM Pariante et al.
BIOLOGICAL PSYCHIATRY (2001)
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy
L Capuron et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Central monoamine activity following acute and repeated systemic interleukin-2 administration
S Lacosta et al.
NEUROIMMUNOMODULATION (2000)
Share Paper
